warrenhochfeld

Second Axsome AXSM buy opportunity

做多
NASDAQ:AXSM   Axsome Therapeutics, Inc.
Current share price is testing the upward trending lower resistance line. As the lower resistance line crosses the $5 inflection line we could expect major movement ahead of the Q42017/Q12018 FDA catalysts.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。